Ever Supreme Bio Technology Co (ROCO:6712) OCF Yield %: 3.30 (As of Jul. 08, 2026) — 41% Above Median


ROCO:6712 Ever Supreme Bio Technology Co Ltd ROCO:6712
88 GF Score
Price NT$177.50
GF Value NT$212.16
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Ever Supreme Bio Technology Co OCF Yield %?

Ever Supreme Bio Technology Co ROCO:6712 +9.91% 88 OCF Yield % is 3.30 as of Jul. 08, 2026, which is 41% above its 10-year median of 2.34. GuruFocus rates ROCO:6712 with a GF Score™ of 88/100 and a GF Value™ of NT$212.16 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 1,407 Biotechnology companies, Ever Supreme Bio Technology Co ranks better than 86.92% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Ever Supreme Bio Technology Co's Trailing 12-Month Cash Flow from Operations is NT$536 Mil, and Market Cap is NT$18,063 Mil. Therefore, Ever Supreme Bio Technology Co's OCF Yield % for today is 3.30%.

The historical rank and industry rank for Ever Supreme Bio Technology Co's OCF Yield % or its related term are showing as below:

ROCO:6712' s OCF Yield % Range Over the Past 10 Years
Min: -1.43   Med: 2.34   Max: 4.76
Current: 3.3


During the past 10 years, the highest OCF Yield % of Ever Supreme Bio Technology Co was 4.76%. The lowest was -1.43%. And the median was 2.34%.

ROCO:6712's OCF Yield % is ranked better than
86.92% of 1407 companies
in the Biotechnology industry
Industry Median: -8.01 vs ROCO:6712: 3.30

Ever Supreme Bio Technology Co's OCF Margin % for the quarter that ended in Dec. 2025 was %.


Ever Supreme Bio Technology Co OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Ever Supreme Bio Technology Co OCF Yield % Related Terms


Ever Supreme Bio Technology Co OCF Yield % Historical Data

* Premium members only.

The historical data trend for Ever Supreme Bio Technology Co's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ever Supreme Bio Technology Co OCF Yield % Chart

Ever Supreme Bio Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.04 2.12 2.94 3.11 3.73

Ever Supreme Bio Technology Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.06 6.79 1.73 2.15 4.50

ROCO:6712 vs VRTX, REGN, ALNY: OCF Yield % Comparison

For the Biotechnology subindustry, Ever Supreme Bio Technology Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ever Supreme Bio Technology Co OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ever Supreme Bio Technology Co's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Ever Supreme Bio Technology Co's OCF Yield % falls into.


ROCO:6712
88GF Score
Ever Supreme Bio Technology Co Ltd ROCO:6712
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ever Supreme Bio Technology Co OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Ever Supreme Bio Technology Co's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=536.346 / 14365.931411052
=3.73%

Ever Supreme Bio Technology Co's annualized OCF Yield % for the quarter that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=161.461 * 4 / 14365.931411052
=4.50%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 3.30 mean?
Ever Supreme Bio Technology Co (ROCO:6712) has a OCF Yield % of 3.30 as of Jul. 08, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Ever Supreme Bio Technology Co and its competitors. This is 41% above median its historical median of 2.34. According to the industry distribution chart, Ever Supreme Bio Technology Co ranks #184 out of 1407 companies in the Biotechnology industry, placing it in the top 13.1%.
Is Ever Supreme Bio Technology Co's OCF Yield % too high?
Ever Supreme Bio Technology Co's current OCF Yield % of 3.30 is 41% above median its 10-year median of 2.34. Based on the distribution chart, Ever Supreme Bio Technology Co ranks #184 out of 1407 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Ever Supreme Bio Technology Co has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ever Supreme Bio Technology Co's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Ever Supreme Bio Technology Co ranks #184 out of 1407 companies for OCF Yield %. This places Ever Supreme Bio Technology Co in the top 13% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Ever Supreme Bio Technology Co and its competitors. Ever Supreme Bio Technology Co's current OCF Yield % is 3.30, which is 41% above median its own 10-year median of 2.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ever Supreme Bio Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Ever Supreme Bio Technology Co (ROCO:6712) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$212.16, compared to a current price of NT$177.50 — trading 16.3% below its estimated fair value. The current OCF Yield % is 3.30, which is 41% above median its 10-year median of 2.34. Ever Supreme Bio Technology Co's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Ever Supreme Bio Technology Co (ROCO:6712), the current OCF Yield % is 3.30 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ever Supreme Bio Technology Co (ROCO:6712) Overvalued in 2026?

Based on GuruFocus' analysis, Ever Supreme Bio Technology Co stock appears to be undervalued. The current stock price of NT$177.50 is trading 16.3% below its estimated GF Value™ of NT$212.16. GuruFocus considers Ever Supreme Bio Technology Co to be Modestly Undervalued.

Key valuation signals for ROCO:6712:

  • OCF Yield %: 3.30 (41% above median its 10-year median of 2.34)
  • GF Value™: NT$212.16 vs. price of NT$177.50 (16.3% below fair value)
  • GF Score™: 88/100 with 5 warning signs

No single metric tells the full story. See the ROCO:6712 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ever Supreme Bio Technology Co Business Description

Address Keya Road, 4th Floor, No. 30, Daya District, Taichung, TWN
Ever Supreme Bio Technology Co Ltd is a Taiwan-based company. The company is engaged in research, development, and manufacturing of new drugs related to human mesenchymal stem cells and immune cells. The company operates in two segments: Cell Preparation Business Unit and Other Operating Business. The company gained a majority of revenue from the Cell Preparation Business, which is engaged in the research, development, manufacture, and sales of various new drugs and cell preparations, and investments related to biotechnology and medical industry businesses.
88GF Score

Get the complete analysis for ROCO:6712

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$177.50
Price
NT$212.16
GF Value